Toluene-2,5-diamine, toluene-2,5-diamine sulfate, and toluene-3,4-diamine are diaminotoluenes used as colorants in permanent hair dyes and tints. Toluene-2,5-diamine is used in 79 products at concentrations up to 3%; toluene-2,5-diamine sulfate is used in 168 products at concentrations up to 4%. Toluene-3,4-diamine does not appear to be in current use. Previously, the Cosmetic Ingredient Review Expert Panel determined that all 3 ingredients were safe for use as hair dyes. New data suggest that differences in toxicity, especially with respect to carcinogenicity, may exist as a function of placement of amine groups around the benzene ring. The Expert Panel concluded that toluene-2,5-diamine and toluene-2,5diamine sulfate and are safe as hair dye ingredients in the present practices of use and concentrations but that there are insufficient data supporting the safety of toluene-3,4-diamine.
As given in the International Cosmetic Ingredient Dictionary and Handbook, toluene-2,5-diamine (CAS No. 95-70-5) is the substituted aromatic amine that conforms to the structure shown in Figure 1 . 4 Toluene-2,5-diamine sulfate (CAS Nos. 615-50-9 and 6369-59-1) is the sulfate salt of toluene-2,5-diamine with the structure depicted in Figure 2 .
Toluene-3,4-diamine (CAS No. 496-72-0) is the substituted aromatic amine that conforms to the formula shown in Figure 3 .
Synonyms for toluene-2,5-diamine; toluene-2,5-diamine sulfate; and toluene-3,4-diamine are found in Table 1 .
Physical and Chemical Properties
Toluene-2,5-diamine is a colorless, crystalline plate that is soluble in water, ethanol, ether, and hot benzene. It is slightly soluble in cold benzene. [5] [6] [7] The sulfate form of toluene-2,5diamine is a white powder that is soluble in water and ethanol. The molecular weight of toluene-2,5-diamine is 122.2 6, 7 and 220.2 for its sulfate. 5 The melting and boiling points for toluene-2,5-diamine are 64 C and 273 C to 274 C, respectively. [5] [6] [7] Toluene-3,4-diamine forms a colorless crystal with a molecular weight of 122. 17 . It is soluble in water and has a melting point of 89 C to 90 C and a boiling point of 265 C (sublimes). 7 The absorption maxima of toluene-2,5diamine were 201, 237, and 285 nm and, in a duplicate experiment, 198, 236, and 302 nm. 8 Toluene-3,4-diamine in methanol absorbs at 297 nm. 9 
Methods of Manufacture
In general, diaminotoluenes are manufactured from dinitrotoluenes using catalytic hydrogenation procedures or by the reaction of iron and hydrochloric acid with dinitrotoluenes. 1 Toluene-2,5-diamine can be manufactured by reductive cleavage of 4-amino-2,3 0 -dimethylazobenzene as reported by Prager et al 10 ; reductive cleavage as reported by Thirtle 11 ; electrolytic reduction of 2,5-dinitrotoluene as reported by Tallec and Gueguen 12 ; or condensation of 2-amino-1-methylbenzene and toluene-4-sulphonyl chloride to 4toluenesolphono-2-toluidide, which is then coupled with diazotized aminobenzenesulphonic acid and reduced as reported by Wlodarski. 13 
Analytical Methods
Methods for separation and/or determination of toluene-2,5diamine and toluene-3,4-diamine in hair dyes are presented in Table 2 . 1 
Impurities
The Scientific Committee on Consumer Products (SCCP) of the European Commission reported that a 50% aqueous solution of toluene-2,5-diamine had greater than 99% highperformance liquid chromatography (HPLC) qualitative purity, 48% to 52% potentiometric titer purity, and the potential impurity o-toluidine less than 50 ppm. The SCCP also reported that toluene-2,5-diamine sulfate (concentration of solution not provided) had greater than 98% wt/wt HPLC quantitative purity, greater than 99% HPLC qualitative (254 nm) purity, a solvent content less than 1%, and the potential impurity o-toluidine less than 50 ppm. 14 
Reactivity
In a study of eosin-sensitized photo-oxidation reactions, toluene-2,5-diamine was an inhibitor, competing efficiently with oxygen and with trypsin for reactions with the triplet state of eosin. Triplet eosin was reduced to the ground state and/or a semi-reduced eosin radical and an oxidized form of 
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International Journal of Toxicology 29(Supplement 2) toluene-2,5-diamine. Toluene-2,5-diamine also competed effectively with trypsin for oxidation by semi-oxidized eosin. 15 
Use Cosmetic
According to information supplied to the US Food and Drug Administration (FDA) by industry as part of the Voluntary Cosmetic Ingredient Reporting Program (VCRP), toluene-2,5-diamine and the sulfate salt are used in a total of 79 and 168 products, respectively. All uses reported for these ingredients are in hair coloring products. The VCRP reported no current uses for toluene-3,4-diamine. 16 According to a survey of current use concentrations conducted by the Cosmetic, Toiletry, and Fragrance Association (CTFA), toluene-2,5-diamine is used at concentrations of 0.2% to 3.0% in hair dyes and colors and toluene-2,5diamine sulfate is used at concentrations of 0.1% to 4.0% in hair dyes and colors and at 3% in hair bleaches. 17 No use concentrations were reported for toluene-3,4-diamine. The available use and use concentration data are given in Table 3 .
According to the International Cosmetic Ingredient Dictionary and Handbook, these 3 ingredients function as oxidative hair colorants. 4 Permanent hair dyes are formed by mixing 3 classes of chemicals: primary intermediates, couplers, and an oxidant, usually hydrogen peroxide. When mixed, these chemicals undergo oxidation and coupling reactions to form colored material inside the hair shaft. The colors are not removed by shampooing. Subsequent dyeing is necessitated by the need to color new hair growth. 18, 19 Toluene-2,5-diamine and toluene-2,5-diamine sulfate are used as primary intermediates in permanent hair dye formulations to produce black, drab and warm browns, and shades of blond and gray. 20 Toluene-2,5-diamine sulfate is also used in formulas for bleach toners for silver (at levels of 0.100%), smoke (0.04%), and platinum blond (0.08%). 21, 20 Hair dye ingredients containing coal tar are not subject to the same FDA requirements as other hair dyes. Since 1938, FDA law has exempted coal tar hair dye products from the principal adulteration and color additive provisions in sections 601 and 706 of the Federal Food, Drug, and Cosmetic Act, when the label bears a caution statement and patch test instructions for determining whether the product causes skin irritation. 22 The caution statement is as follows:
Caution-this product contains ingredients which may cause skin irritation on certain individuals and a preliminary test according to accompanying directions should be made. This product must not be used for dyeing the eyelashes or eyebrows; to do so may cause blindness.
In 1991-1992, the CIR Expert Panel addressed the question of sensitization testing for coal tar hair dye products. There was a general consensus among dermatologists that screening of patients for sensitization (allergic contact dermatitis) should be conducted by the procedures used by the North American Contact Dermatitis Group and the International Contact Dermatitis Group. [23] [24] [25] Basically, these procedures state that the test material should be applied at an acceptable concentration to the patient, covered with an appropriate occlusive patch, and evaluated for sensitization at 48 and 72 hours after application. The CIR Expert Panel has cited the results of these studies in its safety assessments of cosmetic ingredients. The Panel advised the cosmetics industry to recommend that the open patch test be evaluated 48 hours after application of the test material.
In the European Union, methylphenylenediamines, their N-substituted derivatives, and their salts, except for 4-methylm-phenylenediamine, 4-diethylamino-o-toluidine, and toluene-3,4-diamine, have been listed in annex III (part 1) as substances ''which cosmetic products must not contain except subject to the restrictions and conditions laid down.'' 26 Under these conditions, these oxidizing hair coloring agents have a maximum authorized concentration in finished cosmetic products of 10% calculated as free base. Products containing these ingredients intended for general use must have a warning on the labeling. Toluene-3,4diamine has been added to annex II and is not permitted to be used in hair dyes in Europe.
In 2007, the SCCP of the European Commission issued its opinion on toluene-2,5-diamine. It concluded that ''use of toluene-2,5-diamine cannot be considered safe based on the available data'' and that toluene-2,5-diamine is an extremely potent skin sensitizer. 14 If human toxicokinetic data using concentrations approximating those used in hair dyes become available, the SCCP may reevaluate its conclusion.
Toluene-2,5-diamine, its sulfate salt, and toluene-3,4diamine are not included on the list of ingredients that must not be used in cosmetic products that are marketed in Japan. 27 However, in Japan, hair dyes are regulated as quasi-drugs, and all ingredients, both active and inactive, must be specifically approved. Toluene-2,5 diamine, its salts, and toluene-3,4diamine are approved hair dye actives. Quasi-drugs are defined as ''having a mild effect on the body, but are intended for neither the diagnosis, prevention, nor treatment of disease, nor to affect the structure or function of the body.'' 28
Noncosmetic Use
The diaminotoluenes are used as intermediates in the production of dyes used for textiles, furs, leathers, biological stains and indicators, spirit varnishes and wood stains, and pigments. 1 Toluene-2,5-diamine is used as an intermediate in the production of 2 dyes: Cl Basic Red 2 and Cl Acid Brown 103. Cl Basic Red 2 is used to dye fabrics and paper and is used in spirit inks, biological stains, and solvent dyes. Both dyes are used to color leather. 5 General Biology Absorption, Distribution, Metabolism, Excretion Toluene-2,5-diamine. The absorption of toluene-2,5-diamine through the skin of dogs was studied by Kiese et al. 29 A 50-mL solution composed of a typical hair dye formulation and water was used to suspend 1.4 g of toluene-2,5-diamine. The gel was applied to the abdominal skin of dogs for 3 hours (the number of dogs was not specified). The amount of toluene-2,5diamine absorbed into the blood was determined using the Schiff base method. During the 3-hour exposure, the concentration of toluene-2,5-diamine increased to 1 mg/mL of blood. The concentration increased more rapidly during the later stage of the experiment than during the earlier stage. After the gel was removed and the area washed, the concentration in the blood decreased slowly.
To determine the amount of toluene-2,5-diamine that had been absorbed through the skin, the absorption was imitated by a continuous intravenous infusion of toluene-2,5-diamine. An infusion of 0.022 mg of toluene-2,5-diamine per kilogram per minute was administered for 3 hours. During the first 2 hours, the concentration in the blood was greater than that seen in the absorption experiments; after 3 hours of infusion, the concentrations were the same. Because each dog weighed approximately 10 kg, it was calculated that 40 mg of toluene-2,5-diamine had been infused over the 3-hour period. Thus, it was assumed that the same amount was absorbed through the skin of the dogs in 3 hours.
The amount of toluene-2,5-diamine excreted in the urine of dogs after a cutaneous application also was investigated using the Schiff base method. A 50-mL application of gel containing 1.25 g of toluene-2,5-diamine sulfate was applied to the skin of an unspecified number of dogs for 3 hours. Over 24 hours, an average of 0.41 mg of toluene-2,5-diamine was found in the urine; 0.1 mg and trace amounts were detected over the following 2 days. 29 In a similar series of studies regarding the amount of toluene-2,5-diamine absorbed in the blood and excreted in the urine, the addition of 3% hydrogen peroxide reduced absorption of toluene-2,5-diamine. After a 3-hour cutaneous exposure to a gel containing 3% hydrogen peroxide and 1.4 mg of toluene-2,5-diamine, no toluene-2,5-diamine was detected in the blood of dogs. An intravenous infusion of 0.0015 mg of toluene-2,5-diamine per kilogram of body weight per minute for 3 hours produced a detectable concentration of toluene-2,5-diamine. Thus, the absorption through the skin was less than 3 mg. Absorption of toluene-2,5-diamine was proved by the detection of small amounts (60-70 mg) in the urine. 29 Kiese and Raucher assessed the absorption of toluene-2,5diamine through human skin. 30 A simple hair dye containing 2.5 g of toluene-2,5-diamine was applied to the hair and scalp of 5 human subjects for 40 minutes. Because humans excrete toluene-2,5-diamine as N,N 0 -diacetyl-p-toluenediamine (N,N 0dpt) rather than as a free amine, ethyl acetate, instead of chloroform, was used as the solvent for extracting this compound from the urine. The greatest rate of excretion was observed 
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International Journal of Toxicology 29(Supplement 2) during the 5-to 8-hour period following the dyeing. On average, the total amount of N,N 0 -dpt excreted was 3.66 mg, which is equivalent to 2.17 mg of toluene-2,5-diamine.
To estimate the amount of toluene-2,5-diamine absorbed from the amount of the N,N 0 -dpt found in the urine, N,N 0 -dpt concentrations were determined using the same methods after subcutaneous injection of a known amount of toluene-2,5diamine. Three women and 3 men were injected with 2.6 mL of a solution containing 5.54 mg of toluene-2,5-diamine. The rate of excretion was highest during the first few hours after the injection. An average of 4.5 mg of N,N 0 -dpt, or more specifically, 2.64 mg of toluene-2,5-diamine, was isolated from the urine; thus, 47.6% of the injected dose was excreted as N,N 0 -dpt. The authors calculated that 4.6 mg of toluene-2,5diamine was either absorbed during the dyeing process or liberated in vivo from a compound formed during the preparation of the hair dye and absorbed through the skin. 30 The extent of cutaneous absorption was further investigated by Hruby, 31 using rats and dogs, with radioactive toluene-2,5diamine, [Me-14 C] toluene-2,5-diamine.
The skin of 9 female and 9 male Sprague-Dawley rats was treated with 0.5 g of a formulation containing 7.5 mg of radioactive toluene-2,5-diamine (specific activity: 77.8 mCi/g toluene-2,5-diamine) mixed with an equal volume of 6% hydrogen peroxide; the skin was exposed for 30 minutes. Over the 24 hours following application, 0.207% of the total dose was absorbed. The majority of the radioactivity (0.14% of the total dose) was found in the urine. Approximately 0.063% of the radioactivity was found in the total-body homogenate.
An identical experiment was conducted using radioactive compound with a specific activity of 22.2 mCi/g. A total of 0.211% of the total dose was absorbed in 24 hours; 0.08% was found in the urine and 0.13% in the total-body homogenate.
A 1-mL subcutaneous administration of 0.4% aqueous [ 14 C]toluene-2,5-diamine hydrochloride (specific activity: 12.8 mCi/g toluene-2,5-diamine) was given to 18 Sprague-Dawley rats. More than 65% of the radioactivity was excreted in the urine within 24 hours. After 5 days, approximately 15% of the radioactivity was found in the feces, and 6.9% was detected in the total-body homogenate.
The extent of cutaneous absorption also was studied using dogs. Fifty milliliters of a formulation containing 1.4 g of toluene-2,5-diamine ([Me-14 C] toluene-2,5-diamine; specific activity, 32.0 mCi/g toluene-2,5-diamine) was applied for 3 hours to the lateral abdominal region of 6 Beagle dogs. Peak concentrations of radioactivity (925.5 pCi/mL) were reached in the blood at 6 hours. Over 4 days, 0.092% and 0.840% of the administered dose were excreted in the urine and feces, respectively. The site of application retained 1.79 mCi 14 C activity on day 5. 31 Three weeks later, the same dogs were used for an intravenous administration. The infusion consisted of 0.224 g of toluene-2,5-diamine hydrochloride and 0.14 g of toluene-2,5diamine with a specific reactivity of 15.2 mCi/g toluene-2,5diamine dissolved in 27.0 mL of deionized water. Each dog was infused at a constant rate with 9 mL/h of the solution for 3 hours. Within 2 hours of the start of infusion, peak blood concentrations of radioactivity were achieved. Sixty percent of the radioactivity was found in the urine and 19% in the feces over 4 days. The bulk of this radioactivity was found after the first 24 hours.
Eighteen Sprague-Dawley rats were given 1-mL oral doses of a 1.6% aqueous solution of radioactive toluene-2,5-diamine hydrochloride (specific activity, 15.8 mCi/g toluene-2,5-diamine) by stomach tube. Within 24 hours, more than 70% of the radioactivity was excreted in the urine. After 5 days, a total of 10% was detected in the feces, 1.2% was detected in the body homogenate, and 1.4% remained in the gastrointestinal tract. 31 The absorption and elimination of toluene-2,5-diamine were studied in 5 male human subjects. 32 A test formulation was prepared with [Me-14 C]-toluene-2,5-diamine plus unlabeled toluene-2,5-diamine sulfate in a hair dye cream formulation containing 0.825% resorcinol. The final concentration of toluene-2,5-diamine sulfate was 1.65%. This formulation was then mixed with either 100 g of water (1:1) or 100 g of 6% hydrogen peroxide to produce formulation 1 and formulation 2, respectively. The subjects received 1 of the 2 formulations (45 g, containing a total of 371 mg of toluene-2,5-diamine) on a 250-cm 2 area of the scalp. The formulation was thoroughly rinsed off after 30 minutes and the hair was shampooed.
The mean total elimination rate of radioactivity of the applied dose in the urine and the feces was 4.81% + 0.62% for formulation 1 and 1.31% + 0.14% in formulation 2. The amounts of toluene-2,5-diamine sulfate were 71 + 9.26 mg eq / cm 2 for formulation 1 and 20 + 2.02 mg eq /cm 2 for formulation 2. The area under the curve (AUC) for whole blood recovery was 41.6 + 1.7 ng eq Áh/L and 9.2 + 3.1 ng eq Áh/L for formulations 1 and 2, respectively. The total recovery for formulation 1 was 91.2% + 1.73%, whereas the total recovery for formulation 2 was 47.64% + 3.43%. The authors concluded that the lower recovery for formulation 2 was due to higher retention of radiolabel in the hair as a result of the oxidative hair coloring process. Hair was not sampled to confirm this. 32 Toluene-2,5-diamine sulfate. Percutaneous absorption of toluene-2,5-diamine sulfate in human skin samples was studied by Leclerc. 33 Radiolabeled (97.2% pure) and nonradiolabeled (99.7% pure) toluene-2,5-diamine sulfate was added to a final concentration of 9% to 2 hair dye bases, one of which contained an equimolar amount of m-aminophenol as a coupler. The formulation containing the coupler was mixed with hydrogen peroxide (50:50) to yield a test substance with a final toluene-2,5-diamine sulfate concentration of 4.5%. The formulation base without the coupler was mixed with water or hydrogen peroxide, in both cases 50:50, to yield 2 other test substances with final concentrations of toluene-2,5-diamine sulfate of 4.5%. The formulations were then applied over an area of 2-cm 2 to 350-mm-thick human skin (20 mg/cm 2 ) or samples of isolated epidermis mounted in perfusion cells. After an application period of 30 minutes, the test substance was rinsed off with water and a solution of sodium lauryl sulfate.
Most of the test substance (93.5% of the applied dose) was recovered during rinsing at 30 minutes post application. Cumulative penetration (based on radioactivity in the receptor fluid) neared a plateau at approximately 5 hours. The total absorption in the formulation without coupler mixed with water was 4.17% + 2.54% (40.31 + 23.77 mg eq /cm 2 ). In the formulations mixed with peroxide, the total absorption was 3.41% + 1.32% (31.26 + 11.64 mg eq /cm 2 ) with the coupler and 3.44% + 2.84% (32.03 + 26.58 mg eq /cm 2 ) without the coupler. 33 Toluene-2,5-diamine sulfate (0.6%) in acetone/water/olive oil (2:2:1) was assessed by Wyss 34 for dermal penetration potential using pig skin (1 mm thick). The solution of toluene-2,5-diamine sulfate was applied to the skin samples and rinsed off after 30 minutes with water and shampoo.
The amount of radioactivity recovered by rinsing the skin 30 minutes after application was greater than 100% of the amount applied. The total recovery was 107.7%. Cumulative penetration reached a plateau at 16 hours. The total percutaneous absorption was calculated by adding the cumulative amount of substance measured in the receptor fluid and lower skin (lower stratum germinativum and upper dermis). The total absorption of radiolabeled toluene-2,5-diamine sulfate was 31.9 mg eq /cm 2 (5.35% applied dose). 34 Bornatowicz 35 assessed the percutaneous penetration potential of 5.4% toluene-2,5-diamine sulfate using pig skin (560-750 mm thick). Three test formulations were prepared with radiolabeled toluene-2,5-diamine sulfate: formulation A contained the test substance with a resorcinol coupler mixed with water, formulation B contained the test substance with resorcinol coupler mixed with peroxide (final concentration was 3%), and formulation C was the test substance in aqueous solution. Twenty milligrams of each formulation (approximately 1.08 mg/cm 2 toluene-2,5-diamine sulfate) was applied to the skin surface and rinsed off after 30 minutes.
Rinsing 30 minutes after application of the formulations removed most of the applied dose (86.9%-95.8%). Cumulative penetration neared a plateau at approximately 24 hours. The percutaneous absorption was calculated by totaling the measured amounts of radioactivity in the epidermis, dermis, and receptor fluid. The total absorptions were 1.72% (20.8 mg eq / cm 2 ), 2.39% (28.5 mg eq /cm 2 ), and 3.94% (42.0 mg eq /cm 2 ) for formulations A, B, and C, respectively. The author attributed the higher total absorption for formulation C to methodological problems with the first experiment run. 35 Human, rat, and mouse hepatocytes were used to study the metabolic stability and metabolite profile of 98.3% toluene-2,5-diamine sulfate. 36 The primary hepatocytes were cryopreserved from the males of each species (rats strains were Sprague-Dawley, mice strains were ICR/CD-1). In phase I activity, the metabolic capacity was characterized with marker reactions for general cytochrome P450 activity and for CYP 1A1/2, and CYP2E1. Sulfamethazine and p-aminobenzoic acid were used to characterize the phase II enzymes, NAT1 and NAT2. The hepatocytes (1.0 Â 10 6 cells/mL) were incubated with 10 mM toluene-2,5-diamine sulfate in 24-well microtiter plates for 4 hours. Cell viability and metabolite analyses were performed at 0, 0.5, 1.5, and 4.0 hours.
The cell viability of human, rat, and mouse hepatocytes was *90%, 95%, and 80%, respectively. Functional metabolic capacity was demonstrated by the marker reactions. The test material, toluene-2,5-diamine sulfate, was extensively metabolized by the hepatocytes of all 3 species, with rat and mouse equivocal and greater than human. N-acetylation was the major metabolic reaction in all 3 species. The mouse hepatocytes also appeared to produce a hydroxylation metabolite that was not found in the human or rat specimens. 36 Toluene-2,5-diamine sulfate (4.6%) in a hair dye formulation without coupler or hydrogen peroxide was assessed by Wyss 37 for dermal penetration potential using an application area of 4 cm 2 pig skin (0.9 + 0.1 mm thick) with 400 mg of the hair dye formulation applied to the skin samples.
Rinsing 30 minutes after application of the formulations removed most of the applied dose (92.8%). Cumulative penetration neared a plateau at approximately 24 hours. The percutaneous absorption was calculated by totaling the cumulative amount of substance measured in the receptor fluid and upper dermis. The epidermis was not included in the total percutaneous absorption calculations. The total absorption of radiolabeled toluene-2,5-diamine sulfate was 10.5 + 3.2 mg eq /cm 2 (0.2% applied dose), and the total radioactivity recovered was 93.2%. 37 Human hepatic metabolism of 14 C-toluene-2,5-diamine sulfate was investigated by Powrie. 38 The test material was incubated with pooled hepatocytes from 4 female donors, with pooled human liver microsomes (for 20 minutes with and without an NADPH-regenerating system), and with human CYP isozymes CYP1A1, CYP1A2, CYP1B1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 (for 60 minutes). The positive control was 2-aminofluorene. Metabolic reactions were stopped with acetonitrile, and the formation of metabolites was detected with HPLC-mass spectrometry. Oxidative metabolites were not observed after toluene-2,5-diamine sulfate was incubated with the liver microsomes or the CYP isozymes. 2-Aminofluorene was metabolized, as expected, to a number of monohydroxylated metabolites. Incubation of the 14 C-toluene-2,5-diamine sulfate with the human hepatocytes yielded an acetylated metabolite but no sulfated, glucuronidated, or monohydroxylated metabolites.
The absorption, distribution, metabolism, and excretion of 14 C-toluene-2,5-diamine sulfate were investigated in rats in a series of studies by Wenker. [39] [40] [41] [42] In the first study, 39 groups of female Wistar Kyoto rats (4 per group in the mass balance portion of the study and 6 per group in the toxicokinetics portion of the study) received the test substance at either 2.5 or 25.0 mg/kg of body weight in a single oral gavage dose or at 33.3 mg/kg of body weight as a dermal application. Vehicle for the oral groups was water, whereas in the dermal group it was water/acetone (1:1).
In the urine of the oral dose groups after 96 hours, the mean cumulative recovery of the applied dose was 62.2% in the 2.5-mg/kg dose group and 72.9% in the 25-mg/kg dose group, whereas in the feces, the recovery was 31.4% and 22.0%, respectively. The mean mass balance for both oral doses was *98%.
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In the dermal application groups, 10.9% and 2.7% of the applied dose were recovered in the urine and feces, respectively. The mean mass balance for the dermal dose was nearly 100%. Three major metabolites were observed in the urine after oral dosing, with the main metabolite identified as N,N-diacetyl-toluene-2,5-diamine. No parent compound was identified in the urine. Radioactivity in the urine of the dermal dose group was too low for separation and detection of metabolites. In plasma kinetics results, the time to peak concentration (T max ) was 0.5 hours and 0.25 hours for the low-and high-dose oral groups, respectively, indicating rapid absorption. The AUC values for the 2 oral dose groups were 17.59 and 174 mg eq Áh/L, respectively, and for the dermal dose group 4.39 mg eq Áh/L. 39 In the second Wenker study, 40 groups of female Wistar Kyoto rats (6 per group for both mass balance and toxicokinetic evaluations) received a single intravenous injection of toluene-2,5diamine sulfate at 2.5 mg/kg of body weight. The same protocol was followed as in the above study with the oral dose mass balance groups. The values for corrected mean percentage recovery of radioactivity in the urine and feces were comparable to the results of the oral administration described in the above study, as were the 3 major metabolites, with the main metabolite identified again as N,N-diacetyl-toluene-2,5-diamine. The authors stated that plasma concentrations of the parent compound were above the level of detection but were low (values not given).
The protocol described in Wenker 39 was performed by Wenker 41 in Sprague-Dawley rats. T max values of 1 hour were recorded in both oral dose groups, indicating rapid oral absorption of toluene-2,5-diamine sulfate. The T max value for the dermal group was 2 hours. The AUC values for the low-and highdose oral groups were 8.53 and 112 mg eq Áh/L, respectively, and indicated reasonable dose proportionality. The AUCs for the water/acetone and special formulation vehicle dermal groups were 5.00 and 2.27 mg eq Áh/L, respectively. The presence of several metabolites in plasma was indicated with radio-HPLC, but the metabolites were not identified. Concentrations of the parent compound in the plasma were very low or nondetectable.
The final Wenker study 42 followed the same protocol as that described for Wenker 40 except that Sprague-Dawley rats were used. The results were used in combination with Wenker 41 to calculate the bioavailability (F abs ) after oral and dermal application, which was reasonably high in the oral dose groups (53% and 69% in the low and high doses, respectively) and low in the dermal dose groups (2%-3% for both vehicles) when calculated from dose normalized AUC values. After intravenous dosing several metabolites were detected in plasma with radio-HPLC, but these were not identified. Low concentrations of parent compound in the plasma were detectable through the 8-hour time point.
Animal Toxicology Acute Toxicity
Toluene-2,5-diamine. The subcutaneous lethal dose low (LD Lo ) values for toluene-2,5-diamine in rats and rabbits were 50 mg/kg and 100 mg/kg, respectively.
Toluene-2,5-diamine sulfate. The oral median lethal dose (LD 50 ) of toluene-2,5-diamine sulfate in an oil-in-water emulsion for rats was reported as 98 mg/kg; the intraperitoneal LD 50 of the compound in dimethylsulfoxide in rats was 49 mg/kg. 2 A 10% concentration of toluene-2,5-diamine sulfate was administered to CFY strain rats (groups of 5 per sex) by oral intubation at doses of 0, 64, 100, 160, or 250 mg/kg of body weight. Treatment-related effects included lethargy, piloerection, ataxia, and increased salivation. Respiratory rates were increased in the 100-mg/kg dose group and decreased in the dose groups above 100 mg/kg. Using a geometric dose progression of 1.6, the LD 50 value was calculated to be 102 mg/kg. The 95% confidence limits were 69 to 152 mg/kg. Necropsies were performed on the surviving rats. No abnormalities indicative of residual systemic effects were observed. 43 Toluene-3,4-diamine. In a study of the ulcerogenic activity of toluene-3,4-diamine, Sprague-Dawley rats received a subcutaneous injection of toluene-3,4-diamine dissolved in 10% ethanol at doses ranging from 62.5 to 500 mg/kg. The rats were observed for 24 hours. No deaths occurred from doses of 300 mg/kg or lower. Mortality increased progressively at greater doses: groups given 350, 400, 450, and 500 mg/kg had mortalities of 5%, 30%, 50%, and 94%, respectively. The incidence of duodenal lesions increased progressively up to 80% as doses increased to 400 mg/kg. At the 2 highest doses (450 and 500 mg/kg), the incidence decreased to 20% and 27%, respectively. 44 
Short-Term Oral Toxicity
Toluene-2,5-diamine sulfate. In a 14-day toxicity study of 99.7% toluene-2,5-diamine sulfate by Hill, 45 Sprague-Dawley rats received once-daily doses of 7.5, 15, 30, or 60 mg/kg of body weight by oral gavage (10 mL/kg total volume). The dose groups were composed of 10 male and 10 female rats each. A control group of the same size received the vehicle (water) daily through the 14-day dosing period.
One male in the high-dose group died after the blood collection but prior to necropsy. The death did not appear to be treatment related. No other mortalities occurred. Neither treatment-related clinical signs nor effects on body weight, body weight gain, or feed consumption were observed. Minor hematological changes were noted but were within normal reference ranges. In the group receiving 30 mg/kg of body weight per day, females had significantly increased plasma aspartate aminotransferase (AST) levels, and both sexes had increased creatine phosphokinase (CPK) and lactate dehydrogenase (LDH). In the group receiving 60 mg/kg/d, both sexes had increased mean plasma levels of AST, CPK, and LDH. The females of this dose group also had increased alanine aminotransferase (ALT). Absolute and relative liver weights were increased in both sexes of the high-dose group and in males receiving 30 mg/kg/d. All treated females had increased absolute and relative thyroid weights; however, there was no correlation in the histopathological findings in the liver or thyroid. No treatment-related effects were observed at necropsy. Histopathological evaluations found treatmentrelated degeneration of myocytes in heart, tongue, diaphragm, and skeletal muscle in all dose groups, with increased incidence in the groups receiving 30 and 60 mg/kg/d. 45 Toluene-3,4-diamine. Thirteen female Sprague-Dawley rats were fed toluene-3,4-diamine in 2 mL of water (individual dose: 50 mg per 100 g of body weight) twice a day for 5 days by stomach tube. Seven rats died before study termination, and 6 of these had perforated duodenal ulcers. 46 An oral dose of 33.3 mg in 2 mL of water also caused duodenal ulcers. 47 
Subchronic Oral Toxicity
Toluene-2,5-diamine sulfate. Hill 48 conducted a 13-week oral toxicity study of 99.7% toluene-2,5-diamine sulfate in Sprague-Dawley rats. The rats received once-daily doses of 2.5, 5, 10, or 20 mg/kg of body weight by oral gavage (10 mL/kg of body weight total volume). 48 The dose groups were composed of 15 male and 15 female rats each. A control group of the same size received the vehicle (water) daily throughout the 13-week dosing period.
Two moribund males were killed during the study (one in the 10-mg/kg/d dose group on day 57 and the other in the 2.5-mg/kg/d dose group on day 83). The deaths did not appear to be treatment related. No other mortalities occurred. No treatment-related clinical signs or effects to body weight, body weight gain, or feed consumption were observed. Minor hematological and coagulation changes were noted but were within normal reference ranges. Urine volume was increased, whereas urine specific gravity was slightly decreased in the 20-mg/kg/d females at week 4, in the 10-mg/kg/d females at week 13, and in all 20-mg/kg/d animals at week 13. Females in the 5-mg/kg/d and above dose groups had slightly increased serum AST levels after 4 weeks of treatment, but by week 13, AST was only increased in all animals of the high-dose group.
No significant changes in organ weights were observed in any of the treated animals. Animals in the 20-mg/kg/d dose group had increased incidence of abnormally shaped pituitary glands under macroscopic observation, but no abnormalities were observed microscopically.
Two males in the 20-mg/kg/d group, 1 female in the 5-mg/ kg/d group, and 1 male in the 2.5-mg/kg/d group were observed with retinal hyperreflectivity during ophthalmoscopic examinations, and retinal degeneration was determined by histopathology in all 3 of the males. However, it was determined that the lesions were not treatment related and likely represented focal spontaneous retinopathy. From the observations made in this study, the no observable adverse effect level (NOAEL) was determined to be 2.5 mg/kg/d based on the slightly increased AST levels in the 5-mg/kg/d group at 4 weeks but not at 13 weeks. 48 
Subchronic Dermal Toxicity
Toluene-2,5-diamine sulfate. Five hair dye formulations were tested for percutaneous toxicity in New Zealand White rabbits. These formulations contained 0.25%, 0.4%, 0.6%, 3.0%, and 6.0% toluene-2,5-diamine sulfate, as well as various other hair dye constituents. Dosages of 1 mg/kg were applied for 1 hour to either intact or abraded skin of 12 animals twice a week for 13 weeks. The animals were monitored for changes in body weight, urine composition, and either hematological or clinical chemistry abnormalities. No evidence of systemic toxicity was reported. 49 Chronic Dermal Toxicity Toluene-2,5-diamine. Kinkel and Holzmann 50 conducted a long-term percutaneous study of toluene-2,5-diamine in rats. Two groups of 50 male and 50 female Sprague-Dawley rats were treated with solutions containing toluene-2,5-diamine. One solution contained 4% toluene-2,5-diamine and the second solution contained 3% toluene-2,5-diamine and 2 other hair dye constituents, resorcinol and m-diaminoanisole (each at a concentration of 0.75%). A third group of rats served as untreated normal controls, whereas a fourth group of rats (25 male and 25 female) was treated with the vehicle alone. To simulate typical hair-dyeing techniques, the solutions and the vehicle were mixed with 6% hydrogen peroxide immediately before application. Solutions of 0.5 g were applied to the skin of the rats for 30 minutes twice weekly for 2 years. The rats were weighed weekly and observed regularly for behavioral changes.
No cutaneous irritation was evident in any of the rats during the study, and no marked differences in body weight changes were observed among the groups. The mean life span and mortality rate were comparable in the experimental and control groups. The behavior of all the rats was normal. No evidence of treatmentrelated carcinogenicity or other toxic effects were observed.
Giles et al 51 used Swiss-Webster mice in a 2-year toxicity study of hair dye formulations containing 3% toluene-2,5diamine. The formulations also contained 2,4-diaminotoluene, p-phenylenediamine, and resorcinol. Once a week, 0.05 mL of the solutions was applied to the skin of the mice, and the mice were evaluated for signs of toxicity. Survival rates varied greatly in both the experimental and control groups. Average body weight gains for the treated mice were not significantly different from the untreated controls. No abnormal proliferation or maturation of squamous epithelium of the skin was reported.
Toluene-2,5-diamine sulfate. Three hair dye formulations containing 3% toluene-2,5-diamine sulfate were tested for cutaneous toxicity in an 18-month study. 52 The formulations contained various concentrations of other chemical intermediates (p-phenylenediamine, resorcinol, m-phenylenediamine, 2,4-diaminoanisole sulfate, and 2,4-diaminotoluene) and were mixed with 6% hydrogen peroxide just prior to use to simulate conventional hair dyeing techniques. Nine groups of Swiss-Webster mice were given the following treatments: 6 groups were treated with 0.05 mL of the different formulations
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International Journal of Toxicology 29( Supplement 2) once weekly or once every other week, 2 groups had the vehicle alone applied at the 2 dosing frequencies, and 1 positive control group received weekly applications of 0.05 mL of a solution of 7,12-dimethylbenz[a]-anthracene in acetone (total dose during 18 months was *1.9 mg). One group of 250 mice served as an untreated control group. The animals were shaved with an electric clipper to remove hair before treatment.
No signs of systemic toxicity were observed in any of the dyetreated groups. The average body weight for each of the groups was comparable throughout the study. Survival varied from 58% to 80% except in the positive controls, in which only 21% of the mice were alive at the termination of the study. Moderate alopecia was reported in 50% of the animals in each of the 3 groups receiving the dyes once weekly. This occurred during the first 5 months of the study and was not observed in any of the other groups of mice. The alopecia diminished as the study progressed and the hair coat appeared normal after 11 months. Sections of the treated skin were normal when examined microscopically. 52 
Dermal Irritation and Sensitization
Toluene-2,5-diamine. An assessment of dermal irritation was conducted using New Zealand White rabbits. Toluene-2,5diamine was applied as a 2.5% (wt/vol) preparation to the intact and abraded skin of 3 rabbits. Slight erythema and edema were observed at the intact site of all the animals. One rabbit had very slight erythema at the abraded site. The primary irritation index was estimated to be 0.3. No signs of irritation were observed after 72 hours. 43 The irritancy potential of a 50.6% solution of toluene-2,5diamine was studied in 3 male New Zealand White rabbits. 53 A single 0.5-mL dose of the test substance (pH 9.71) was prepared on a dry compress and applied to a 6-cm 2 clipped area of skin. The area was covered with semi-occlusive dressing for 4 hours. After the material was removed, the patch site was observed for skin reactions at 1, 24, 48, and 72 hours and then daily until day 6. No edema, ulceration, or necrosis was observed. Erythema reactions could not be assessed because of the coloration of the skin by the test material.
A guinea pig maximization test investigating the skin sensitization potency and cross-reactivities in hair-dye-related chemicals, including p-toluenediamine 2HCl (PTD; hydrochloride salt of toluene-2,5-diamine) was performed by Xie et al. 54 Six animals were induced with PTD at 0.1% in saline by intradermal injection at a site previously treated with sodium lauryl sulfate 10% in petrolatum. The animals were challenged with all 5 hair dye chemicals under investigation in the study at dilutions from 0.1% to 0.001%, applied topically. All 6 animals had positive sensitization reactions to PTD at 0.1% according to Draize criteria. Crossreactions in the PTD-induced guinea pigs occurred in 5/6, 3/6, 5/ 6, and 1/6 challenges with p-phenylenediamine, p-aminophenol, p-aminoazobenzene, and Sudan III (a tar dye), respectively, at 0.1%. The authors concluded that PTD was a strong sensitizer.
Toluene-2,5-diamine sulfate and toluene-3,4-diamine. Hartley albino guinea pigs were used to study the cutaneous irritation and sensitization potential of toluene-2,5-diamine sulfate and toluene-3,4-diamine. Concentrations of 0.1%, 0.2%, 0.5%, 1%, 2%, 5%, and 10% toluene-2,5-diamine sulfate or toluene-3,4-diamine were mixed with white petrolatum and applied under occlusive patches to the flanks of 10 animals for 48 hours. No animal treated with toluene-2,5-diamine sulfate had irritation. However, 30% of the guinea pigs treated with 10% toluene-3,4-diamine had cutaneous irritation. No irritation was caused by toluene-3,4-diamine at lower concentrations. 55 During the 2-week induction phase of the sensitization experiment, a 1% concentration of either toluene-2,5-diamine sulfate or toluene-3,4-diamine in white petrolatum was applied under occlusive patches to the nape of 10 guinea pigs for 48 hours 3 times per week. The animals were given a 2-week nontreatment period before they received challenge applications of either 1% or 0.1% toluene-2,5-diamine sulfate and toluene-3,4diamine. The challenge applications were made under occlusive patches to the flanks of the test animals for 48 hours, and the animals were observed 24 and 48 hours after the test materials had been removed. The sensitization rates for 0.1% and 1% toluene-2,5-diamine sulfate were reported to be 10% and 40%, respectively. Toluene-3,4-diamine was a strong sensitizer; sensitization rates were 90% and 100% at concentrations of 0.1% and 1.0%, respectively. 55 Local Lymph Node Assay Toluene-2,5-diamine sulfate. In a local lymph node assay study performed by Albrecht, 56 CBA female mice were divided into groups of 5 and received 0%, 0.5%, 1.5%, or 2.8% toluene-2,5-diamine sulfate in water/acetone (1:1) mixed with olive oil (4:1) or 0%, 0.5%, 1.5%, or 5.0% toluene-2,5-diamine sulfate in dimethyl sulfoxide (DMSO) on each ear lobe (25 mL per ear) once daily for 3 consecutive days. The positive control was pphenylenediamine at 1% in DMSO in parallel with identical test conditions. On day 5, all animals were injected intravenously with 250 mL of [ 3 H] methyl thymidine. Around 5 hours after injection, the animals were killed and the auricular lymph nodes were excised. Single cell suspensions were prepared per mouse, with the cells precipitated by trichloroacetic acid and radioactivity measured by liquid scintillation. The stimulation index (SI) was calculated.
No deaths or clinical signs of toxicity were observed during treatment. Body weight development was not affected in the water/acetone/olive oil groups. In the water/acetone/olive oil vehicle groups, the SIs were 4.4, 10.4, and 19.4 for 0.5%, 1.5%, and 2.8% toluene-2,5-diamine sulfate, respectively. The SI of the positive control was 5.3. The SI was affected in a dose-dependent manner. The extrapolated EC 3 theoretical concentration value was 0.31%. In the groups treated with DMSO vehicle, the SIs were 4.9, 4.2, and 3.7 for 0.5%, 1.5%, and 5.0% toluene-2,5-diamine sulfate, respectively. The SI of the positive control was 10.1. No dose response was observed, and no EC 3 value was determined with the DMSO vehicle group. The author concluded that toluene-2,5-diamine sulfate induced biologically relevant, dose-dependent immune responses when tested in water/acetone/olive oil vehicle and that an equivocal result occurred in DMSO vehicle. Toluene-2,5-diamine sulfate was a skin sensitizer under the conditions of this study. 56 
Ocular Irritation
Toluene-2,5-diamine. A 2.5% wt/vol solution of toluene-2,5diamine in 0.05% aqueous sodium sulfite (0.1-mL volume, pH 7.0) was instilled in 1 eye of 3 rabbits (strain and sex not reported). The eyes were rinsed for 10 seconds after treatment with 50 mL of lukewarm water. The eyes were evaluated and scored according to Draize at 1 hour and on days 1, 2, 3, 4, and 7. Toluene-2,5diamine was determined to be nonirritating in this study. 57 Lloyd et al 43 conducted an eye irritancy test on New Zealand White rabbits. A 2.5% (wt/vol) solution of toluene-2,5-diamine was instilled into the conjunctival sacs of 3 rabbits. After 10 seconds of exposure, the eyes were rinsed with water. Mild conjunctival inflammation was observed; however, these reactions did not persist for more than 24 hours.
Toluene-2,5-diamine (50.6% in aqueous solution; 0.1-mL volume; pH 9.71) was instilled into the conjunctival sac of the left eye of a single male New Zealand White rabbit. The right eye of the rabbit served as a control and was not treated. The eyes were not rinsed and were evaluated per Draize protocol at 1, 24, 48, and 72 hours after application and then daily until day 8. Marked conjunctival irritation with chemosis and redness, slight iridal irritation, and moderate to slight corneal opacity were observed in the treated eye. The reactions were reversed within 7 to 8 days of exposure. It was concluded that toluene-2,5diamine was irritating to rabbit eyes and that the high pH of the test substance may have contributed to the irritation. 58 Toluene-2,5-diamine sulfate. The ocular irritancy potential of toluene-2,5-diamine sulfate was studied using the chorioallantoic membrane of 6 freshly fertilized White Leghorn chicken eggs in a HET-CAM test. 59 The test material was undiluted (99.9% pure) and was applied to the chorioallantoic membrane and rinsed off with physiological saline after 30 seconds. Texapon ASV 70 (sodium magnesium laurylmyristyl-6-ethoxysulfate) at a concentration of 5% was used as a reference material, as it is defined as moderately irritating to rabbit eyes in vivo. End points of hemorrhage, coagulation, and blood vessel lysis were semiquantitatively scored at 30 seconds (for the reference material) or 180 seconds (for the test material) after rinsing. The end points were scored as 0, 0, and 0, respectively, for toluene-2,5-diamine sulfate. In the reference material, the end points were 12, 9, and 0, respectively. The author predicted that toluene-2,5-diamine sulfate is not more than slightly irritating to mucous membranes, including the eye.
Reproductive and Developmental Toxicity Toluene-2,5-Diamine
The teratogenic potential of toluene-2,5-diamine was studied in pregnant JCL:ddN mice. A 50-mg/kg dose of toluene-2,5diamine dihydrochloride dissolved in distilled water was injected subcutaneously into 8 groups of 10 or 11 mice on one of days 7 to 14 of gestation. The mice were terminated on day 18 of gestation, and the uteri and fetuses were examined for abnormalities. The greatest teratogenic effects were observed in the mice dosed on day 8; 18% of the fetuses had craniofacial malformations. These mice also had a greater incidence of fused or distorted thoracic vertebrae associated with absent or fused ribs. No fused or distorted vertebrae were observed in the control mice and did not occur at all or occurred to a much lesser extent in mice treated on the other 7 days. All of the mice survived to termination, and no significant differences in the incidence of intrauterine deaths were found between groups and the untreated controls. 60 Based on these results, a more detailed analysis of the teratogenicity of toluene-2,5-diamine was carried out on an additional 2 groups of mice. On day 8 of gestation, a larger dose of toluene-2,5-diamine dihydrochloride (75 mg/kg) was administered subcutaneously to a group 10 mice, and 50 mg/kg was administered intraperitoneally to a group of 12 mice. Six dams from the subcutaneously treated group and 4 dams from the intraperitoneal group died before termination. Nearly half of the fetuses in both groups were either dead or reabsorbed. Thirty-five percent of the fetuses from the subcutaneously treated mice and 45% of those from the intraperitoneally treated mice had craniofacial and skeletal malformations. 60 
Toluene-2,5-Diamine Sulfate
Five hair dye formulations containing various levels of toluene-2,5-diamine sulfate (0.25%, 0.4%, 0.6%, 3%, and 6% toluene-2,5-diamine sulfate) were cutaneously tested for teratogenic effects on pregnant Charles River CD rats. Four of these formulations were permanent hair dyes, which were mixed with hydrogen peroxide before application, and 1 formulation (containing 0.25% toluene-2,5-diamine sulfate) was a semipermanent dye. Five groups of 20 rats were given 2 mL/kg topical applications (on both controls and noncontrols) on days 1, 4, 7, 10, 13, 16, and 19 of gestation. The hair on the back of the rats was clipped short to ensure maximum skin contact. A positive control group received acetylsalicylic acid by gavage, and 3 negative control groups received no treatment. All animals were killed on day 20. No significant differences in the mean number of corpora lutea, live fetuses, and resorptions per pregnancy were reported for the experimental animals. There were no significant changes in soft tissue anomalies between the fetuses of the treated groups and the negative controls. A statistically significant increase in skeletal anomalies (9 of 169 fetuses) was reported for the group of rats receiving the hair dye formulation containing 3% toluene-2,5-diamine sulfate. No adverse changes occurred from hair dye formulations containing 6% toluene-2,5-diamine sulfate. 49 Pregnant outbred albino (CD-1) mice were given subcutaneous injections of 16, 32, 48, or 64 mg/kg/d toluene-2,5diamine sulfate on days 6 to 15 of gestation. The mice were killed on day 18, and maternal and fetal abnormalities were recorded. Toluene-2,5-diamine sulfate was lethal to 4 of
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International Journal of Toxicology 29(Supplement 2) 31 dams and 9 of 11 dams receiving dosages of 48 and 64 mg/kg/ d, respectively. A significant trend (P < .05) toward maternal weight reduction with increased dosage was reported. Also, a significant decrease (P < .05) in fetal weight was reported for dams receiving dosages above 32 mg/kg/d. Although 4 of 31 dams receiving 48 mg/kg/d and 9 of 11 dams receiving 64 mg/kg/d died, toluene 2,5 diamine sulfate did not cause a significant increase in the average percentage of malformed fetuses. 61 A teratogenicity study of toluene-2,5-diamine sulfate was performed on groups of 16 New Zealand White rabbits. 62 Pregnant females received 0, 10, 25, or 50 mg of the test material per kilogram of body weight per day on days 6 through 18 of gestation via oral gavage. A positive control group of 18 rabbits received vitamin A (6 mg/kg/d). The animals were observed daily for mortality, and clinical signs of toxicity and body weights were measured on days 0, 6, 18, and 28 of gestation. The rabbits were killed on day 28, and the fetuses were examined for abnormalities and macroscopic changes.
Five rabbits died during the study; the mortalities were not related to the test substance. No clinical signs of toxicity or macroscopic anomalies were observed in the animals of any dose group. Maternal body weight gain was within normal parameters, and there were no treatment-related effects on pregnancy incidence, number of implantations, pre-implantation loss, or number, size, weight, or sex of the fetuses. There were no significant increases in skeletal anomalies in the fetuses. The positive control agent did not produce teratogenic effects and had minimal embryotoxicity, which the author concluded was likely due to too low of a dose. The NOAEL for maternal toxicity, teratogenicity, and embryotoxicity in this study was 50 mg/kg/d. 62 In another teratogenicity study by Osterburg, 63 pregnant Sprague-Dawley rats (groups of 23) received toluene-2,5diamine sulfate once daily at 10, 50, or 80 mg/kg of body weight per day from day 6 through 15 of gestation via oral gavage. A positive control group received 15 mg/kg/d vitamin A. The animals were observed daily for mortality and clinical signs of toxicity, and body weights were measured on days 0, 6, 15, and 19 of gestation. The rats were killed on day 19, and the fetuses were examined for abnormalities and macroscopic changes.
Two rats died during the study; the mortalities were not related to the test substance. No clinical signs of toxicity were observed in the animals of any dose group. Body weight gain was retarded during treatment in the 50-and 80-mg/kg/d dose groups, but this effect was only statistically significant in the 80-mg/kg/d dose group. There were no treatment-related effects on pregnancy incidence, pre-implantation loss, or weight or sex of the fetuses. There were no significant increases in skeletal or visceral anomalies in the fetuses when compared with historical ranges. The positive control produced marked teratogenic effects. The NOAEL for maternal toxicity for toluene-2,5-diamine sulfate was 50 mg/kg/d and the NOAEL for embryotoxicity and teratogenicity was 80 mg/kg/d. 63 A 2-generation reproduction study of the effects of toluene-2,5-diamine sulfate by Bornatowicz 64 was performed on Sprague-Dawley rats. Groups of 24 males and 24 females received the test material at 5, 15, or 45 mg/kg of body weight per day once daily via gavage. The males of the parental generation received the test material for the 70-day period prior to mating period, whereas the females received the test material for the 14-day period prior to mating and continuing through lactation. From the F 1 generation, 24 males and 24 females per dose group were selected and received the same doses of test material as their parents via gavage from ages 21 to 80 days old. The F 1 -generation rats were then mated and received the test material until the end of the lactation period in the F 2 generation. Litters were examined on days 1 or 2, 4, 7, 14, and 21. Litter size reduction was carried out on day 4 to 4 pups per sex. Pup development was observed until the end of the lactation periods. Histopathology was performed on organs with abnormalities, on parents without live offspring, and on all parent animals of the control and high dose groups. Microscopic examination of the reproductive organs was also performed.
During the study, 4 rats died from accidental intubation lesions. There were no dose-dependent differences in body weight gain, feed consumption, or clinical signs between control and test groups in the parental or F 1 generations. There were no treatment-related effects on fertility, breeding, or postnatal development in males or females, nor were there any significant observations in the histopathology of the high-dose groups when compared with the controls. Absolute and relative pituitary gland weights were increased in F 1 females, but there were no significant histopathology observations and fertility was not affected. The control group F 0 females did have a significantly greater number of ovarian cysts. The author concluded that toluene-2,5-diamine sulfate was neither a reproductive nor a developmental toxicant when administered over 2 generations in rats. The NOAEL for this study was 45 mg/kg/d. 64 Burnett and Goldenthal 65 conducted a 2-generation reproduction study using rats that received cutaneous applications of 2 oxidative hair dye formulations containing 3% and 6% toluene-2,5-diamine sulfate. Each formulation (0.5 mL) was applied to the skin of 40 Sprague-Dawley rats twice weekly. When the rats were 100 days old, they were mated to produce an F 1 generation. These offspring were subsequently used to produce an F 2 generation using the same procedures. Observations were made during the growth, mating, gestation, and lactation phases of the F 0 parents to the weaning of F 1 and F 2 litters. Comparisons of male and female fertility, gestation, and fetal viability indices and body weights were made between the experimental groups and untreated control rats. Mild dermatitis was noted during the treatment period in each generation. However, all the rats appeared to be healthy throughout the study; no signs of pharmacotoxicity, teratogenicity, or reproductive abnormalities were reported.
Toluene-3,4-Diamine
Becci et al 66 studied the teratogenic potential of o-toluenediamine, a mixture of toluene-2,3-diamine and toluene-3,4diamine (40:60), in rats and rabbits. Groups of pregnant Sprague-Dawley rats (22-25 animals) were given daily oral doses of 10, 30, 100, and 300 mg/kg on days 6 to 15 of gestation. O-toluenediamine was dissolved in corn oil at appropriate concentrations so that the mixture was administered at 10 mL/ kg/d to each group. Positive control rats were given aspirin (2.5% suspension administered at 250 mg/kg/d), and negative controls received corn oil (10 mL/kg/d). The rats were observed daily and weighed regularly. On day 20 of gestation, the dams were killed and the uterine contents examined.
The mean weight gain of the high-dose (300 mg/kg/d) dams and their fetuses was significantly different from that of the negative control group. The fetuses of the high-dose group had an elevated incidence of missing sternebrae and of incomplete ossification of vertebrae. An elevated incidence of the latter malformation also occurred in the 100-mg/kg group. The authors noted that these malformations were indicative of delayed fetal development. Weight gain was normal in the dams and fetuses of the lower dosage groups, and the numbers of live fetuses, implantation sites, and resorption sites were normal for all groups. The fetuses from the rats of the lower dosage groups had neither skeletal nor soft tissue malformations related to treatment with o-toluenediamine. The authors concluded that o-toluenediamine was not teratogenic to Sprague-Dawley rats. The adverse effects on the fetus occurred only at dosages that were toxic to the dam.
A similar study was also conducted using Dutch-Belted rabbits. 66 Doses of 3, 10, 30, and 100 mg/kg/d of o-toluenediamine were administered orally to groups of pregnant rabbits (15 or 16 animals) on days 6 to 18 of gestation. O-toluenediamine was dissolved in corn oil at appropriate concentrations so that 2 mL/ kg/d of the mixture was administered. A positive control group was given 6-aminonicotinamide as a 0.125% aqueous solution (2.5 mg/kg on day 9). Negative control animals were given corn oil alone (2 mL/kg/d). On day 29 all the rabbits were terminated and the uterine contents examined.
The mean weight gain of the high-dose (100 mg/kg/d) rabbits and their fetuses was significantly smaller than that of the negative control animals. The dams also had a greater number of resorption sites. The mean number of fetuses per dam was decreased in this group, but the difference was not statistically significant. None of the dams or fetuses from the lower dose groups had any of these changes. No fetuses from any of the treatment groups had skeletal malformations. The authors concluded that o-toluenediamine was not teratogenic. Increased resorption rates and delayed fetal development occurred only at dosages that were toxic to the dam. 66 Genotoxicity A summary of the genotoxicity data discussed below is provided in Table 4 .
Bacterial Assays
Toluene-2,5-diamine. Ames et al 67 tested 169 different permanent hair dyes for mutagenicity using Salmonella typhimurium strain TA1538. Of 169 dyes, 150 (89%) were mutagenic both before and after mixing with hydrogen peroxide. Some of these dyes were mutagenic alone, and others required microsomal (S9) activation. Toluene-2,5-diamine, a common constituent in these hair dyes, was weakly mutagenic when activated with S9. When oxidized with hydrogen peroxide and spot tested with S9, toluene-2,5-diamine was strongly mutagenic; there was a 40fold increase in revertants.
The mutagenicity of toluene-2,5-diamine, along with several other p-phenylenediamine hair dye ingredients, was studied by Chung et al 68 in an Ames test using Salmonella strains TA98 and TA100, with and without metabolic activation. The standard plate-incorporation and pre-inoculation procedures were followed, and the positive controls were 2-aminofluorene, 2-nitrofluorene, and N-methyl-N 0 -nitro-N-nitroguanidine (MN-NG). Doses per plate ranged from 1 to 3000 mg. Toluene-2,5diamine was mutagenic with and without metabolic activation. The positive controls gave the expected results.
Toluene-2,5-diamine sulfate. Sokolowski 69 reported the results of an Ames test conducted on toluene-2,5-diamine sulfate in DMSO. S typhimurium strains TA1537, TA98, TA1535, TA 100, and TA102 were used to study the mutagenic potential of this chemical. The concentration range was 0 to 5000 mg per plate, and the plates were cultured in triplicate with or without S9 metabolic activation. Positive controls without S9 were 4-nitro-o-phenylenediamine (TA98 and TA1537), sodium azide (TA100 and TA1535), and methyl methane sulfonate (TA102). The positive control with S9 in all strains was 2-aminoanthracene. In the presence of S9, substantial and dose-dependent increases in revertant colony numbers were observed in all strains except TA102. No mutagenic effect was observed in any of the strains in the absence of S9. Toxic effects were observed at 2500 and 5000 mg per plate. The positive controls gave expected results. Toluene-2,5-diamine sulfate in the presence of metabolic activation induced gene mutation under the conditions of this experiment.
Toluene-3,4-diamine. Toluene-3,4-diamine was not active in the standard Ames plate incorporation testing using S typhimurium strains TA98 and TA100 with and without metabolic activation. 70 Florin et al 71 used the Ames test to evaluate the mutagenic potential of toluene-3,4-diamine (3 mmol/plate), using S typhimurium strains TA98, TA100, TA1535, and TA1537 both with and without metabolic activation. Toluene-3,4-diamine was nonmutagenic.
Watanabe et al 72 tested the mutagenic potential of toluene-3,4-diamine alone and with the addition of H 2 O 2 using the Ames test. S typhimurium strain TA98 was used both with and without metabolic activation with S9. Toluene-3,4-diamine and its oxidation products were not mutagenic in either system.
Mammalian Cell Assays
Toluene-2,5-diamine. Greene and Friedman 73 tested toluene-2,5-diamine for its ability to enhance the transformation of
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International Journal of Toxicology 29(Supplement 2) primary hamster embryo cells (HECs) by simian adenovirus 7 (SA7) and for its ability to transform secondary HECs. Cultures of primary HECs were treated with toluene-2,5-diamine (at a concentration range of 3.13-50 mg/mL) 18 hours prior to the addition of SA7, or 48 hours immediately after absorption of SA7 (at a concentration range of 1-200 mg/mL). For both protocols, toluene-2,5-diamine was active, producing an absolute increase in the number of virus-transformed foci per plate. A dose-response relationship was observed in 1 set of cells treated prior to the addition of the virus. Toluene-2,5-diamine also transformed secondary HECs (at concentrations of 5 and 10 mg/mL) but did not produce a clear dose-response relationship. The authors concluded that toluene-2,5-diamine has a low but definite potential for inducing genetic damage. In a study by Chung et al, 68 the mutagenicity and toxicity of toluene-2,5-diamine in Chinese hamster ovary (CHO) cells were evaluated. The median toxic concentration (TC 50 ) for the test chemicals was established using exponentially growing CHO cells incubated for 24 hours with different concentrations of the test chemicals in D-MEM/F-12 medium. The TC 50 for toluene-2,5-diamine was 22 + 2 mg/mL. CHO-K1 cells were then incubated with controls or test chemicals at doses equivalent to 1/2, 1, 2, or 3 times TC 50 without metabolic activation for 2 hours. A positive dose-related increase in chromosomal aberration was observed with toluene-2,5-diamine. Also noted were very dramatic decreases in numbers of metaphases at 81 mg/mL. Toluene-2,5-diamine sulfate. Kornbrust and Barfknecht 74 conducted a study in which the DNA repair induced by toluene-2,5-diamine sulfate was determined in rat and hamster hepatocytes using the primary hepatocyte culture/DNA repair assay. Hepatocytes obtained from male Sprague-Dawley rats and male Golden Syrian hamsters were treated with toluene-2,5-diamine sulfate at molar concentrations of 10 À4 , 10 À5 , 10 À6 , and 2 Â 10 À7 . Two sets of assays were done. An average net nuclear count of 5 or greater was reported as a positive response because these values differed from the control net nuclear counts by more than 2 standard deviations. The 10 À4 mol/L treatment was toxic in both types of hepatocytes. At 10 À5 , the test material produced a positive response (net nuclear count, 8.2 and 5.9) in the rat hepatocytes and a weak positive response (net nuclear count, 4.1 and 2.5) in the hamster hepatocytes. The lower concentrations of toluene-2,5-diamine sulfate had negative responses. The primary purpose of this study was to determine relative differences in DNA repair responses between the rat and hamster hepatocytes, not to evaluate the genotoxic status of toleune-2,5-diamine sulfate; thus, no statistical comparisons between data from control and experimental hepatocytes were performed. 74 Mouse lymphoma TK þ/À L5178Y cells were used in a cell mutation assay of toluene-2,5-diamine sulfate. 75 After a rangefinding test to measure relative suspension growth, 2 independent mutagenicity experiments were performed. The concentrations in the first experiment were 1, 3, 6, 10, or 15 mg/mL without S9 metabolic activation and 3, 10, 30, 60, or 100 mg/ mL with S9. In the second experiment, the concentrations were 1, 6, 10, or 15 mg/mL without S9 metabolic activation and 3, 10, 30, or 100 mg/mL with S9. The vehicle control was 1% vol/vol ammonium hydroxide in culture media. The positive controls were ethylmethanesulfonate without S9 and benzo[a]pyrene with S9. The incubation period in both experiments was 4 hours, with and without metabolic activation. Single cultures were investigated for each concentration and test group, and the mutant frequency and cell survival were measured.
In the range-finding assay, concentrations greater than 3 mg/mL without S9 and 10 mg/mL with S9 yielded toxic effects. In both mutagenicity experiments without S9, toxic effects were observed at concentrations 6 mg/mL and above. No toxicity was observed in the experiments with S9 at any concentration tested. The controls yielded expected results. It was concluded that toluene-2,5-diamine sulfate did not induce mutation at the thymidine kinase locus in mouse lymphoma TK þ/À L5178Y cells in either experiment, although the assay was not definitive given the lack of toxicity with the metabolically activated test groups. 75 The clastogenic potential of toluene-2,5-diamine sulfate was assessed using V79 CHO cells. 76 A range-finding experiment was used to determine the concentrations of the test material to be evaluated with and without S9 metabolic activation. The concentrations tested for induction of chromosome aberrations without S9 were 0.6, 1.3, 2.5, 5, 10, or 20 mg/mL and those tested with S9 were 100, 200, 300, 400, 500, or 600 mg/mL. The culture medium served as the negative control, whereas ethylmethane sulfonate (without S9) and cyclophosphamide (with S9) were the positive controls. The main experiment consisted of 2 cultures per experimental group for cytogenetic analysis and 2 cultures per group for determination of cell number. The treatment period was 4 hours with a 14-hour recovery in both the presence and the absence of S9. Cytogenetic analysis for chromosome aberrations was performed on 100 metaphases per culture (200 metaphases total), and polyploidy screening was performed in 500 metaphases per culture (1000 cells total).
In the range-finding assay, toxicity occurred at all concentrations after 4-and 24-hour exposures without S9. In the 4-hour exposure with S9, toxicity was observed at 276.3 mg/mL and above. In the main experiment, toxicity was observed in the absence of S9 at test concentrations of 10 mg/mL and greater; in the presence of S9, toxicity was observed at 400 mg/mL and greater. A dose-related increase in cells with chromosome aberrations was observed at concentrations of 2.5, 5, and 10 mg/mL in the absence of S9 (maximum of 14.5% aberrant cells induced). In the presence of S9, a doserelated increase in the percentage of aberrant cells was observed at concentrations of 200, 300, and 400 mg/mL at 5.5%, 7.5%, and 18.5%, respectively. No increase in polyploid cells was observed when compared with the controls. The positive controls yielded the expected results. The author concluded that toluene-2,5-diamine sulfate was clastogenic to V79 CHO cells with and without metabolic activation under the conditions of this study. 76 Toluene-3,4-diamine. Toluene-3,4-diamine was also active in the transformation protocols of Greene and Friedman. 73 Toluene-3,4-diamine was administered at concentrations of 12.5 to 200 mg/mL to primary HECs prior to the addition of SA7 or at concentrations of 10 to 200 kg/mL after the addition of SA7. A dose-response relationship was observed in both protocols, and an absolute increase in the number of foci per dish at all dosages occurred when toluene-3,4-diamine was administered prior to SA7 addition. Toluene-3,4-diamine (at concentrations of 2.5-10 mg/mL) also enhanced secondary HEC transformation. However, at higher concentrations (15-50 mg/mL), no transformation occurred.
Animal Assays
Toluene-2,5-diamine. A dominant lethal test of toluene-2,5diamine was conducted on Charles River CD rats. The test material was administered as a 0.2% aqueous solution in a dose volume of 1 mL per 100 g of body weight. Twenty male rats were given intraperitoneal injections (20 mg/kg) 3 times per week. After 8 weeks, the rats were mated for 5 days. The female rats were terminated 17 days later and examined for evidence of increased postimplantation fetal loss. No significant differences were reported between the experimental and control groups. 77 Matheson 78 conducted a recessive spot test with toluene-2,5-diamine dihydrochloride in corn oil. Female C57BL/6J rats were mated with T stock males. On days 9, 10, and 11 postfertilization, the test material was applied to the shaved dorsal surface of the females at doses of 15, 150, or 1500 mg/kg of body weight. Benzo[a]pyrene served as the positive control. No toxic effects were observed in the treated rats, and the test material did not affect fertility or litter size. There were no significant increases in recessive spots. The positive control induced a significant increase in recessive spots. It was concluded that toluene-2,5-diamine dihydrochloride did not induce somatic mutations in vivo.
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A dominant lethal test of toluene-2,5-diamine dihydrochloride in corn oil also was conducted on mice (strain not specified). The test material was applied topically to the shaved dorsal surface of male mice at doses of 1.5, 15, or 150 mg/kg of body weight per day for 5 consecutive days. The males were then mated with 2 females per week starting 2 days after the last application and continuing for 7 weeks. The mice were not prevented from ingesting the test material during the treatment period. Approximately 14 days after the midweek of being caged with the male, the female mice were killed and analyzed. No indication of dominant lethality was observed. The positive control, triethylenemelamine, induced the expected dominant lethal response. 79 Soares and Lock 80 conducted a recessive spot test with toluene-2,5-diamine. T-stock and C57BL/6J (or C57BL/10J) strains of mice were used in the following matings: C57BL/ 6J (or C57BL/l10J) males mated with C57BL/6J females, and T-stock males mated with C57BL/6J females. The pregnant females were given intraperitoneal injections of 30 mg/kg toluene-2,5-diamine or Hanks balanced salt solution (to serve as controls). The total volume of each injection was 0.1 mL. There were no significant differences in number or morphology of offspring between the experimental and control groups. No evidence of mutagenicity was reported, as none of the offspring from the experimental groups had recessive spots.
Toluene-2,5-diamine sulfate. Toluene-2,5-diamine sulfate was nonmutagenic when tested in CFY rats with the micronucleus test. A 120-mg/kg dose of toluene-2,5-diamine sulfate was administered by gastric intubation to 5 male and 5 female rats as 2 equal doses separated by a 24-hour interval. The animals were killed 6 hours after the second dose was administered, and bone marrow slides were prepared. The mean incidence of micronucleated cells per 2000 polychromatic erythrocytes (PCEs) per rat was 0.9; this value did not fall outside the laboratory standard range for negative control groups. 81 Toluene-2,5-diamine sulfate significantly inhibited the incorporation of [ 125 I]-iododeoxyuridine into murine testicular DNA in a dose-dependent manner. Groups of 10 mice were given intraperitoneal injections of toluene-2,5-diamine sulfate at doses of 40, 44.5, 49.5, and 55 mg/kg. Control mice were given 100 mg/kg of dimethylnitrosamine perorally. After 3 hours, 10 mCi [ 125 I]-iododeoxyuridine was injected intraperitoneally. The testes were removed 30 minutes later for analysis. As the doses increased, the radioactivity incorporated into the testicular DNA decreased; the radioactivity in the DNA decreased from 1.77 disintegrations per minute (dpm)/mg DNA (control animals) to 0.99 dpm/mg DNA (high-dose animals 55 mg/kg). Because toluene-2,5-diamine sulfate was capable of reaching the testes and permeating target cell membranes at this site, toluene-2,5-diamine sulfate might represent a genetic health hazard to animals. 82 Völkner 83 studied the mutagenic potential of toluene-2,5diamine sulfate in a micronucleus test. The main study was preceded by 2 range-finding studies. In the main study, mice received the test material at 15, 50, or 150 mg/kg of body weight. Each treatment group was composed of 5 males and 5 females. There were also vehicle (polyethylene glycol 400) and positive (cyclophosphamide) control groups. All mice were killed at 24 hours with the exception of an additional high-dose group, which was killed at 48 hours. Bone marrow was sampled upon death in all mice. One thousand PCEs per animal were studied for the presence of micronuclei. Normochromatic erythrocytes (NCEs) were also studied for micronuclei. The PCE/NCE ratio was measured in 1000 erythrocytes as an indicator for bone marrow toxicity.
Animals were observed with toxic effects, but the details of these effects were not provided. The PCE/NCE ratio was not affected in any of the dose groups. In all dose groups, the number of micronucleated PCEs was not increased when compared with the vehicle control group. The positive control group yielded expected results. Toluene-2,5-diamine sulfate was not a mutagen under the conditions of this study. 83 The mutagenic potential of toluene-2,5-diamine sulfate was evaluated using a micronucleus test. 84 The main study was preceded by 2 range-finding studies. Mice received toluene-2,5diamine sulfate at 25 or 75 mg/kg of body weight. The test material was administered by intraperitoneal injection. In the main study, mice received the test material at 25, 50, or 90 mg/kg of body weight. Each treatment group was composed of 5 males and 5 females. There were also vehicle (ethanol/ deionized water, 20:80 vol/vol) and positive (cyclophosphamide) control groups.
All mice were killed at 24 hours with the exception of additional 50-and 90-mg/kg dose groups, which were killed at 48 hours. Bone marrow was sampled upon death in all mice. Two thousand PCEs per animal were studied for the presence of micronuclei. NCE were also studied for micronuclei. The ratio of nucleated cells to erythrocytes was measured in at least 400 cells per mouse, and the PCE/NCE ratio was measured in 1000 erythrocytes.
The 90-mg/kg dose group had marked toxic effects at 24 hours and none of the mice in the 48-hour group survived until the marrow harvest. Because of the high mortality, the additional 50-mg/kg dose group was added to the study. The 90-mg/kg dose group males had significant decreases in the numbers of nucleated cells, the numbers of PCEs, and the PCE/NCE ratio at 24 hours. Males and females of the 50-mg/kg dose group had systemic toxicity and slight bone marrow toxicity at 24 hours.
In all dose groups, the number of micronucleated PCEs was not increased when compared with the vehicle control group, and there was no influence on the frequency of micronucleated NCEs. The positive control group yielded expected results. It was concluded that toluene-2,5-diamine sulfate was not a mutagen. 84 An unscheduled DNA synthesis study of toluene-2,5diamine sulfate was conducted on Sprague-Dawley male rats. 85, 86 The rats received a single oral gavage dose of the test material at 20, 40, or 80 mg/kg of body weight. Each dose group was composed of 4 rats, 3 of which were processed for the assay. A vehicle control group received 10 mL/kg sterile injectable water and a positive control group received 80 mg/kg methylnitrosourea (for the 2-hour sacrifice group) and 100 mg/ kg 2-acetylaminofluorene.
In the 80-mg/kg dose group, all animals that were prepared for the 14-hour observation died, so the 40-mg/kg dose was considered the high-dose group for the study. Slides prepared from the 80-mg/kg dose group for the 2-hour observation were analyzed at a later time. 85, 86 No response was seen in any of the doses at the 2-hour or 14-hour evaluation point. Controls were within historical ranges, and the positive control treatment yielded a 50% increase in response.
In a Comet assay by Sekihashi et al, 87 ddy mice and Wistar rats in groups of 4 males received toluene-2,5-diamine sulfate at 60 mg/kg of body weight by single dosing via oral gavage. Untreated and vehicle (saline) control groups were composed of 12 males each. The animals were killed 3, 8, or 24 hours after treatment, and the stomach, colon, liver, kidney, urinary bladder, lung, brain, and bone marrow were examined.
No treatment-related deaths or clinical signs of toxicity were reported during the study. No data were provided on the gross or histopathological examination of the organs. The mean migration values from the mice at the 3 sampling periods were not statistically different from the untreated control in any organ. Statistically significant increases in the mean migration values (.001 < P < .01) were observed in the rat stomachs of the 8-hour sample group. No other sample times or organs in the rats had significant findings. The authors concluded that toluene-2,5-diamine sulfate was genotoxic in rats in the Comet assay but suggested that the effects observed in the stomach of the 8-hour group may be due to localized irritation/toxicity. 87 Toluene-3,4-diamine. The methods described earlier by Greene et al 82 also were used to study the effect of toluene-3,4-diamine on murine testicular DNA synthesis. Doses of 200, 229, 262, and 300 mg/kg toluene-3,4-diamine were administered intraperitoneally to mice. 82 The amount of radioactivity incorporated into the testicular DNA decreased as the dosage of toluene-3,4-diamine increased. Radioactivity decreased from 0.79 dpm/mg (control) to 0.44 dpm/mq (high dose, 300). The authors concluded that toluene-3,4-diamine was a potential genetic health hazard to animals. 82 
Carcinogenicity

Toluene-2,5-Diamine
Two groups of 50 male and 50 female Sprague-Dawley rats were treated with hair dyes containing toluene-2,5-diamine in a 2.5-year percutaneous study. One solution contained 4% toluene-2,5-diamine alone and the second solution contained 3% toluene-2,5-diamine with other hair dye constituents (resorcinol and m-diaminoanisole). The hair dyes were mixed with 6% hydrogen peroxide immediately before application, and 0.5 g of the solutions were applied to the shaved skin of the rats for 30 minutes twice weekly for 2 years. Fibroadenomas, fibromas, lymphosarcomas, and round-cell sarcomas were reported during the second half of the life of both groups of rats but not in the area of application of any of the substances. The incidence of the neoplasms and the proportion of male and female rats affected were not significantly different from those observed in vehicle and untreated control rats. None of the neoplasms in the experimental animals developed at the site of application. The authors concluded that neither of these hair dyes induced carcinogenic effects. 50 In its overall evaluation of toluene-2,5-diamine, the International Agency for Research on Cancer 88 concluded that there was inadequate evidence to regard this amine as carcinogenic to animals.
Toluene-2,5-Diamine Sulfate
In conjunction with the 18-week toxicity study and the 2-generation reproduction studies described earlier in this report, Burnett et al 52 and Burnett and Goldenthal 65 reported that no evidence of carcinogenic activity was observed from topical applications of hair dyes containing 3% or 6% toluene-2,5-diamine sulfate. In the toxicity study, the incidence of alveologenic adenomas and carcinomas in the 3 groups of Swiss-Webster mice treated with 3% toluene-2,5-diamine sulfate was comparable to that reported in control groups. The incidence, type, and distribution of other neoplasms were not significantly different. 52 A bioassay of toluene-2,5-diamine sulfate for possible carcinogenicity was conducted by the National Cancer Institute. 89 Fifty Fischer 344 rats of each gender and 50 B6C3F1 mice of each gender were given doses of toluene-2,5-diamine sulfate in their feed for 78 weeks. The rats received toluene-2,5diamine sulfate at concentrations of either 0.06% (the dose was 0.05% for the first 15 weeks) or 0.2%, and the mice received either 0.06% or 0.1%. The animals were monitored for changes in body weight and rate of survival, and clinical observations were made regularly.
There was no evidence that toluene-2,5-diamine sulfate accelerated the mortality of either sex of either species. In both the low-and high-dose male rats, the incidence of interstitial cell neoplasms of the testis was statistically significant (43/ 48 rats in the low dose group and 47/48 rats in the high-dose group had such neoplasms). However, the development of these neoplasms was not attributed to toluene-2,5-diamine sulfate because spontaneous incidence of these neoplasms is known to be both high and variable in male Fischer 344 rats. The incidence of neoplasms in treated female rats was not significantly different from control rats.
In the study using the B6C3F1 mice, there was no significant increase in the development of neoplasms in the male mice of either treatment group. The high-dose-treated female mice had an elevated incidence of alveolar/bronchiolar adenomas and carcinomas (8/45 mice had 1 or both types of neoplasms). It was concluded that the data did not provide sufficient evidence of a compound-related effect. 89 
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In the multigeneration study, 120 F 1 -generation Sprague-Dawley rats were given topical applications of the same hair dyes as their parents (containing either 3% or 6% toluene-2,5-diamine sulfate) twice a week for 2 years. A wide variety of nonneoplastic lesions was observed in both the experimental and control groups. The incidence of neoplasms was highly variable in all of the groups and could not be directly correlated to hair dye exposure. 65 
Toluene-3,4-Diamine
No data on the carcinogenic potential of toluene-3,4-diamine are available; however, the National Toxicology Program reported that 2,4-diaminotoluene, an isomer, is carcinogenic in male and female F344 rats and in female B6C3F 1 mice. 90
Clinical Assessment of Safety Dermal Sensitization
Lynde and Mitchell 91 patch-tested 66 hairdressers with 1% toluene-2,5-diamine in petrolatum. Details of their methods were not given. Five subjects had positive reactions.
Patches of toluene-2,5-diamine (1% in petrolatum) were applied to the skin of 9 beauticians with allergic contact dermatitis. Readings were taken 72 hours after the patch was applied. Positive reactions were reported in 7 of the beauticians. 92 Toluene-2,5-diamine was tested for its sensitization potential in 31 men using the maximization test. Two percent aqueous toluene-2,5-diamine was used for induction and challenge. None of the subjects were sensitized. 93 Lisi and Hansel 94 investigated the cross-sensitization potential of prohaptens to aromatic chemicals with amino substituents in the para position and the chemical reactivity of the substituent groups. The researchers focused on the rate of sensitivity to benzoquinone (BQ) and benzene derivatives in subjects with a positive patch test history to at least 1 hapten of the para group. Twenty-two volunteer patients sensitized to p-phenylenediamine were patch-tested with serial dilutions of BQ (in white petrolatum) and a series of 1,4-substituted benzene derivatives, including toluene-2,5-diamine. Twenty contact-dermatitis patients without allergy to para compounds served as controls and were tested with the BQ serial dilutions. In addition, patch tests with the 1,4-benzene derivatives and with p-phenylenediamine base (1% petrolatum) were performed on 116 contact dermatitis patients with sensitivity to 1 or more para allergens.
Of the 22 volunteer patients, 4 had positive reactions to BQ. Of these 4 patients, 2 had positive reactions to toluene-2,5diamine. In the 116 patients, 29 (25%) had positive reactions to toluene-2,5-diamine. The authors determined that BQ was not a sole or major intermediate in cross-sensitization of para group haptens. They proposed that cross-sensitization may be influenced by the structures of para substituents, although the groups may also have significant effects on percutaneous penetration. 94 Koopmans and Bruynzeel 95 investigated the potential of using p-phenylenediamine as a screening agent for contact allergy to para compounds and disperse dyes. The researchers analyzed data from 2375 patients patch-tested with the European standard series from 1996 to 1999. Patients with positive reactions to p-phenylenediamine were further patch-tested with a series of para and azo dyes, including toluene-2,5diamine sulfate. Data from 551 patients who had already been tested directly with the dyes series after reported contact allergy were also analyzed. In those patients patch-tested with para compounds (n ¼ 154), 15 had positive reactions to toluene-2,5-diamine sulfate and 14 of 15 were positive to pphenylenediamine. The authors found a significant correlation between p-phenylenediamine allergy and sensitivity to toluene-2,5-diamine sulfate. Overall, they concluded that p-phenylenediamine was an adequate screening agent for hair dyes but not disperse dyes.
Uter et al 96 analyzed the data from patch-tested females in Austria, Germany, and Switzerland from 1995 to 2002. The subjects were subdivided into 2 groups: 884 hairdressers with current or previous occupational skin problems and 1217 clients. Clients were women with no known occupational exposures to hair care products. The majority of the subjects in the study were patchtested with the hairdresser series. The study was standardized to account for the differences in the average age of the 2 groups.
An increase in the incidence of contact allergy to toluene-2,5-diamine was observed in the clients over time (8.7% in 1995-1996 vs 13.2% in 2001-2002) . No such trend was observed in hairdressers; in fact, a decrease in contact allergy incidences was noted (29.5% in 1995-1996 vs 24.8% in 2001-2002) . A parallel increase in contact allergy to the developing agent p-aminophenol was also observed in the clients. 96 In a retrospective study of 300 hairdressers patch-tested with the European Standard series and specific hairdressing products between 1994 and 2003 in Spain, 15.33% had positive reactions to toluene-2,5-diamine sulfate. The results were compared with a previous retrospective study (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) of 379 hairdressers, in which 6.8% had positive reactions to toluene-2,5-diamine sulfate. 97 
Case Reports
Hopkins and Manoharan 98 reported 2 cases of aplastic anemia in 2 female patients who had used a hair dye containing toluene-2,5-diamine.
In the first case, a 31-year-old housewife presented with bruising, stomal ulceration, and recurrent skin infections 2 weeks after using the hair dye and 6 weeks after a tubal ligation with general anesthesia. Blood counts fell into the range of severe aplastic anemia. Bone marrow aspirate and trephine biopsy showed marked hypoplasia of all hemopoietic series with a relative increase in lymphocytes and plasma cells. The patient underwent a bone marrow transplant 6 weeks after presentation. Complications from graft-versus-host disease arose 4 weeks later, and the patient died from severe infection.
In the second case, a 62-year-old housewife presented with 1 week of spontaneous bruising. The patient had regularly used hair dye containing toluene-2,5-diamine and last used it 2 weeks before presentation. Blood counts indicated severe aplastic anemia. The patient was treated with packed cell and platelet transfusions, methylprednisolone, antithymocyte globulin, and oxymetholone and was fully recovered 18 months later. The authors of this case report noted that although it is difficult to prove that toluene-2,5-diamine was the etiological factor of the anemia cases, no other cause could be found. 98 
Hair Dye Epidemiology
Hair dyes may be broadly grouped into oxidative (permanent) and direct (semipermanent) hair dyes. The oxidative dyes consist of precursors mixed with developers to produce color, whereas direct hair dyes are a preformed color. Toluene-2,5diamine, toluene-2,5-diamine sulfate, and toluene-3,4diamine are oxidative hair dyes. Although the safety of individual hair dye ingredients is not addressed in epidemiology studies that seek to determine links, if any, between hair dye use and disease, such studies do provide broad information. The CIR Expert Panel noted the conclusions of these reviews, including that personal use of hair colorants cannot be evaluated as to its carcinogenicity and that occupation as a hairdresser or barber entails exposures that are probably carcinogenic, 99 insufficient evidence exists to support a causal association between personal hair dye use and a variety of tumors and cancers such as acute leukemia, bladder cancer, multiple myeloma, and non-Hodgkin's lymphoma, 100 and the epidemiological evidence for personal use of hair colorants is inadequate and is not classifiable as to its carcinogenicity to humans. 101 A summary of the available hair dye epidemiology data is available at http://www.cir-safety.org/findings.shtml.
Summary
Toluene-2,5-diamine, toluene-2,5-diamine sulfate, and toluene-3,4-diamine are diaminotoluenes used as colorants in permanent hair dyes and tints. Toluene-2,5-diamine is used in a total of 79 products at concentrations up to 3%, and toluene-2,5diamine sulfate is used in a total of 168 products at concentrations up to 4%. No formulation data were available for toluene-3,4-diamine.
Toluene-2,5-diamine and toluene-2,5-diamine sulfate penetrated the skin of rats, dogs, pigs, and humans. The extent of penetration varied according to the vehicle; incorporation into hair dye formulation generally reduced penetration. The major routes of excretion after cutaneous absorption were through the urine and feces. Toluene-2,5-diamine sulfate was extensively metabolized into N-acetylated metabolites in mouse, rat, and human hepatocytes.
The oral LD 50 values of toluene-2,5-diamine sulfate in an oil-in-water emulsion and 10% toluene-2,5-diamine sulfate in rats were 98 and 102 mg/kg, respectively. The intraperitoneal LD 50 of toluene-2,5-diamine sulfate for rats was 49 mg/kg. Subcutaneous doses of 450 and 500 mg/kg of toluene-3,4diamine, dissolved in 10% ethanol, caused mortality rates of 50% or greater in Sprague-Dawley rats. Toluene-3,4-diamine also markedly increased the incidence of duodenal lesions when given at doses between 250 and 400 mg/kg.
In a 14-day oral study, rats treated with 30 and 60 mg/kg/d toluene-2,5-diamine sulfate had increased AST levels and increased CPK, LDH, and ACT. Increases in absolute and relative liver and thyroid weights were also observed in these dose groups, but there were no histopathological findings in these organs. Treatment-related degeneration of the myocytes in the heart, tongue, diaphragm, and skeletal muscle were observed in the 7.5-, 15-, 30-, and 60-mg/kg treatment groups, but with increased incidence in the 30-and 60-mg/kg/d dose groups.
In a short-term study, toluene-3,4-diamine was toxic to Sprague-Dawley rats. More than 50% of the rats given twicedaily oral doses (50 mg per 100 g of body weight) died within 5 days. Most of these animals had perforated duodenal ulcers.
The NOAEL for an oral subchronic toxicity study of 99.7% toluene-2,5-diamine sulfate in Sprague-Dawley rats was 2.5 mg/kg/d. There was no evidence of percutaneous toxicity to New Zealand White rabbits when 6% toluene-2,5-diamine sulfate was applied to intact or abraded skin during a 13-week study.
In a 2-year study, no toxicity was reported in rats receiving biweekly cutaneous applications of formulations containing 3% to 4% toluene-2,5-diamine. Swiss-Webster mice were also unaffected by 3% toluene-2,5-diamine sulfate in an 18-month study or by 3% toluene-2,5-diamine in a 2-year study.
New Zealand White rabbits suffered from slight dermal irritation after exposure to 2.5% toluene-2,5-diamine sulfate, but no irritation occurred in rabbits after exposure to 50.6% toluene-2,5-diamine sulfate. A guinea pig maximization test found 0.1% hydrochloride salt of toluene-2,5-diamine to be a strong sensitizer.
No irritation was observed in guinea pigs after exposure to 10% solutions of toluene-2,5-diamine sulfate or toluene-3,4-diamine. The sensitization rates of 0.1% and 1% toluene-2,5-diamine sulfate to guinea pigs were 10% and 40%, respectively. Toluene-3,4-diamine was a strong sensitizer, having rates of 90% and 100% at concentrations of 0.1% and 1%, respectively.
In a local lymph node assay, toluene-2,5-diamine sulfate was a skin sensitizer at concentrations between 0.5% and 5% when tested in acetone/olive oil and DMSO vehicles. A doseresponse relationship was observed in groups tested with the acetone/olive oil vehicle, but no such relationship was observed in the DMSO vehicle test groups.
Toluene-2,5-diamine (2.5%) caused mild, transitory conjunctival inflammation in one study with rabbits but was nonirritating in another study. Toluene-2,5-diamine sulfate was slightly irritating to mucous membranes, including the eye, in a HET-CAM test.
Pregnant mice treated with a 50-mg/kg subcutaneous dose of toluene-2,5-diamine dihydrochloride yielded fetuses with craniofacial malformations and fused or distorted thoracic vertebrae associated with absent or fused ribs. These teratogenic effects were most prevalent in the mice dosed on day 8. Treatment-related maternal death occurred before study
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termination. Half of the fetuses from both groups were either dead or reabsorbed. Craniofacial and skeletal malformations were observed in the fetuses. Cutaneous exposure to hair dye formulations containing 3% toluene-2,5-diamine sulfate caused a statistically significant increase in fetal skeletal anomalies in rats. Rats treated with 6% toluene-2,5-diamine sulfate did not have this adverse response. Toluene-2,5-diamine sulfate caused maternal death and decreases in dams and fetuses in mice at 32 to 64 mg/kg/ d, but no significant teratogenic effects were observed. The NOAEL for maternal toxicity, teratogenicity, and embryotoxicity in a rabbit study of toluene-2,5-diamine sulfate was 50 mg/ kg/d. Toluene-2,5-diamine sulfate was toxic to pregnant rats and their embryos at oral doses of 80 mg/kg/d. Doses between 10 and 50 mg/kg/d did not cause congenital or maternal abnormalities. In a 2-generation reproduction study, mice receiving cutaneous applications of hair dye formulations containing either 3% or 6% toluene-2,5-diamine sulfate had no signs of pharmacotoxicity, teratogenicity, or reproductive abnormalities. Rats receiving toluene-2,5-diamine sulfate up to 45 mg/kg/d orally in a 2-generation reproductive test did not have reproductive or developmental effects.
O-Toluenediamine, a mixture of 2,3-TD and toluene-3,4diamine (40:60), was not teratogenic when administered orally to Sprague-Dawley rats or Dutch-Belted rabbits. There was an increase in resorption rate and skeletal abnormalities, but these changes occurred only at concentrations that were toxic to the dams (300 mg/kg/d for rats and 100 mg/kg/d for rabbits).
Toluene-2,5-diamine was mutagenic in Ames tests using S typhimurium strains TA98, TA100, and TA1538, with and without S9 activation. Toluene-2,5-diamine sulfate was mutagenic in an Ames test with S9 activation only. Toluene-3,4diamine was not active in Ames tests.
Primary hamster embryo cells were transformed by toluene-2,5-diamine and toluene-3,4-diamine both prior to and after the addition of SA7. Dose-response relationships were demonstrated. Toluene-2,5-diamine and toluene-3,4-diamine also transformed secondary hamster embryo cells but did not demonstrate a dose-response relationship. Toluene-2,5-diamine was clastogenic in a CHO cell assay. Toluene-2,5-diamine sulfate did not induce mutation in a mouse lymphoma TK þ/À assay, but it was clastogenic in a CHO cell assay.
Toluene-2,5-diamine was nonmutagenic in recessive spot or dominant lethal tests. Toluene-2,5-diamine sulfate was nonmutagenic in micronucleus tests using mice and CFY rats. Toluene-2,5-diamine sulfate did not induce unscheduled DNA synthesis in rats, but it was genotoxic to rats in a Comet assay. Toluene-2,5-diamine sulfate and toluene-3,4-diamine were identified as potential genetic health hazards to animals. Murine testicular DNA synthesis decreased in a dose-dependent manner when these ingredients were injected intraperitoneally into mice.
A bioassay of toluene-2,5-diamine sulfate for carcinogenicity was negative in rats fed either 0.06% or 0.2% toluene-2,5-diamine sulfate and in mice fed either 0.06% or 0.1% toluene-2,5-diamine sulfate. No evidence of carcinogenicity was reported in several studies of rats and mice treated with cutaneous applications of hair dyes containing either 3% or 4% toluene-2,5-diamine and either 3% or 6% toluene-2,5diamine sulfate.
No data on the carcinogenic potential of toluene-3,4diamine are available; however, 2,4-diaminotoluene, an isomer, is carcinogenic in rats and mice.
Toluene-2,5-diamine was a sensitizer in clinical studies. Two cases of aplastic anemia were reported in patients that had used a hair dye containing toluene-2,5-diamine.
The most recent comprehensive review of available epidemiology studies concluded that there is insufficient evidence to support a causal association between personal hair dye use and a variety of tumors and cancers. A summary of the available hair dye epidemiology data is available at http://www. cir-safety.org/findings.shtml.
Discussion
The available safety test data, including genotoxicity and animal carcinogenicity data, were sufficient to support the safety of toluene-2,5-diamine and toluene-2,5-diamine sulfate as used in hair dyes.
The Expert Panel recognized that toluene-2,5-diamine sulfate may be a fetal toxicant when given orally, but the data demonstrate such effects only at levels that were maternally toxic and not at levels below that. Because the use of hair dye involves a short exposure time and rinsing off the scalp, maternally toxic levels could not be reached.
The Expert Panel noted that toluene-2,5-diamine was slightly irritating or nonirritating to the skin of rabbits, whereas the sulfate was not irritating to rabbits. Dermal sensitization study results for both toluene-2,5-diamine and its sulfate are mixed, but a maximization study and a local lymph node assay were positive, so these ingredients could be considered moderate to strong skin sensitizers.
In considering hair dye epidemiology data, the CIR Expert Panel concluded that the available epidemiology studies are insufficient to conclude there is a causal relationship between hair dye use and cancer and other end points, based on lack of strength of the associations and inconsistency of findings. Use of direct hair dyes, although not the focus in all investigations, appears to have little evidence of any association with adverse events as reported in epidemiology studies.
The CIR Expert Panel determined that there were insufficient data supporting the safety of toluene-3,4-diamine. Although some genotoxicity data are available, the Expert Panel is concerned that differences in toxicity, especially with respect to carcinogenicity, may exist as a function of placement of amine groups around the benzene ring. For example, toluene-2,5-diamine was not carcinogenic, whereas the isomer 2,4-diaminotoluene has been considered to be carcinogenic in animal studies. The Expert Panel concluded that data are needed to resolve the question about the carcinogenicity of the 3,4 isomer. The additional data needed for the Expert Panel to make a determination as to the safety of toluene-3,4-diamine include dermal absorption data at concentrations and conditions of use and animal carcinogenicity data.
Amended Conclusion
On the basis of the data presented in this report, the CIR Expert Panel concludes that toluene-2,5-diamine and toluene-2,5diamine sulfate are safe as hair dye ingredients in the present practices of use and concentration as described in this safety assessment, but the available data are insufficient to support the safety of toluene-3,4-diamine as a hair dye ingredient.
